T. Rowe Price Associates’s Vapotherm, Inc. Common Stock VAPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-4,519
Closed -$18K – 2921
2023
Q2
$18K Hold
4,519
– – ﹤0.01% 2867
2023
Q1
$24K Hold
4,519
– – ﹤0.01% 2848
2022
Q4
$97K Hold
4,519
– – ﹤0.01% 2723
2022
Q3
$58K Buy
4,519
+1,675
+59% +$26.2K ﹤0.01% 2814
2022
Q2
$58K Buy
2,844
+901
+46% +$33K ﹤0.01% 2842
2022
Q1
$216K Buy
1,943
+723
+59% +$90.3K ﹤0.01% 2687
2021
Q4
$202K Sell
1,220
-2,375
-66% -$411K ﹤0.01% 2759
2021
Q3
$640K Buy
3,595
+352
+11% +$71.6K ﹤0.01% 2259
2021
Q2
$613K Buy
3,243
+427
+15% +$72.8K ﹤0.01% 2291
2021
Q1
$541K Buy
2,816
+691
+33% +$160K ﹤0.01% 2329
2020
Q4
$457K Buy
+2,125
New +$474K ﹤0.01% 2279

Other funds holding VAPO

T. Rowe Price Associates's VAPO Position: Q3 2023 in Review

T. Rowe Price Associates sold out of Vapotherm, Inc. Common Stock (VAPO) in Q3 2023, closing a stake of 4,519 shares — an estimated $18K sold.

T. Rowe Price Associates first reported a position in VAPO in Q4 2020 and held it in 11 quarters. The position peaked at $640K in Q3 2021. 30 funds tracked by Wall St. Rank hold VAPO as of Q3 2023.

  • T. Rowe Price Associates reported no remaining Vapotherm, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 4,519 Vapotherm, Inc. Common Stock shares in Q3 2023, an estimated $18K.
  • T. Rowe Price Associates first reported a position in Vapotherm, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • T. Rowe Price Associates's Vapotherm, Inc. Common Stock position peaked at $640K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Vapotherm, Inc. Common Stock as of Q3 2023.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.